Bill Few Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $490K | Buy |
10,595
+633
| +6% | +$29.3K | 0.14% | 111 |
|
|
2025
Q1 | $608K | Sell |
9,962
-28
| -0.3% | -$1.71K | 0.22% | 85 |
|
|
2024
Q4 | $565K | Buy |
9,990
+125
| +1% | +$7.07K | 0.2% | 86 |
|
|
2024
Q3 | $510K | Buy |
9,865
+160
| +2% | +$8.28K | 0.18% | 100 |
|
|
2024
Q2 | $403K | Buy |
9,705
+101
| +1% | +$4.19K | 0.15% | 111 |
|
|
2024
Q1 | $521K | Buy |
9,604
+450
| +5% | +$24.4K | 0.21% | 84 |
|
|
2023
Q4 | $470K | Buy |
9,154
+725
| +9% | +$37.2K | 0.21% | 88 |
|
|
2023
Q3 | $489K | Sell |
8,429
-325
| -4% | -$18.9K | 0.26% | 74 |
|
|
2023
Q2 | $560K | Sell |
8,754
-75
| -0.8% | -$4.8K | 0.29% | 71 |
|
|
2023
Q1 | $612K | Buy |
8,829
+800
| +10% | +$55.4K | 0.34% | 62 |
|
|
2022
Q4 | $578K | Hold |
8,029
| – | – | 0.34% | 63 |
|
|
2022
Q3 | $570K | Sell |
8,029
-200
| -2% | -$14.2K | 0.39% | 57 |
|
|
2022
Q2 | $634K | Hold |
8,229
| – | – | 0.41% | 53 |
|
|
2022
Q1 | $601K | Buy |
8,229
+324
| +4% | +$23.7K | 0.33% | 58 |
|
|
2021
Q4 | $493K | Buy |
+7,905
| New | +$493K | 0.26% | 69 |
|